Upcoming Meetings

Upcoming Meetings

HPMA Virtual meetings are held on the 2nd Monday of each month at 5:00 p.m. Please see the event calendar for more details.


Follow us on twitter!


Default

Contact HPMA

 

HPMA is a professional organization and does not have any employees of its own. Our work is made possible by our volunteers and through administrative support provided by Hawaii Medical Association


To contact HPMA, you may write, call or send us an e-mail.  

Hawai’i Psychiatric Medical Association

P.O. Box 2785
Honolulu, HI 96803

 

 

Email: [email protected]

 

HPMA Membership

In order to be a member of HPMA you must join the American Psychiatric Association (APA).
Join APA

APA Membership Categories:

Medical Student Member (MS) - Individuals who are enrolled in a U.S. or Canadian school of medicine, including osteopathic medicine, and remain enrolled therein. Medical Student Members are dues exempt and are required to belong at the national level only (exempt from dual membership requirement).

Members-in-Training (MT) - Physicians who have been accepted into a psychiatric residency training program that is approved by the ACGME, RCPS(C), or AOA and remain enrolled therein. Residents enrolled in a one- year primary care training program to be followed by an approved psychiatric residency are eligible for Member-in-Training status. Your First Year of APA Dues as a Member-in-Training is waived! After that, your annual national dues are only $80/U.S. and $50/Canada.

General Members (GM) - Physicians who have completed an acceptable program of training in psychiatry, and hold either a valid license to practice medicine or hold an academic, research, or governmental position that does not require licensure. General Members may apply for Fellowship or be nominated for Distinguished Fellowship provided they meet the eligibility requirements.

International Member (IM) - Physicians who live outside the United States and Canada and who meet the criteria established for General Members. Applicants for this category must be licensed physicians who have completed an acceptable program of training in psychiatry; they must also have the support of one APA member (not including Medical Students and Members-in-Training).

International Fellow (IF) - Physicians who live outside the United States and Canada and who meet the criteria for Fellowship (i.e., having made significant and continued contributions to the field of psychiatry) and who have the support of one Fellow and/or International Fellow of APA.

 

Leadership

2023-2024 Executive Council

Gerald Busch, MD - President

Jennifer Lyman, MD - President Elect

Shelly Wong, MD - Secretary

Heather Miura, MD - Treasurer

Helen Blaisdell-Brennan, MD Immediate Past-President (2020-2021)

Vacant - Member in Training Deputy Representative

Leslie Gise, MD - Membership Committee Chair

Helen Blaisdell-Brennan, MD - Membership Committee Chair

Allison Chang, MD - Resident Fellow Member

Executive Council Legislative Chair

Christina Yoneshige, MD - Early Career Psychiatrist Rep

 

2022-2023 Executive Council

Helen Blaisdell-Brennan, MD - President

Gerald Busch, MD - President Elect

Gerald Busch, MD - Secretary

Julienne Aulwes, MD - Treasurer

Rika Suzuki, MD Immediate Past-President (2020-2021)

Vacant - Member in Training Deputy Representative

Leslie Gise, MD - Membership Committee Chair

Jamie Stevens, MD - Membership Committee Chair

Celia Ona, MD - Ethics Committee Chair

Executive Council - Legislative Chair

Rika Suzuki, MD - Communications Public Affairs Chair

2020-2021 Executive Council

Rika Suzuki, MD - President

Vacant - Vice President

Julienne Aulwes, MD - Secretary

Julienne Aulwes, MD - Treasurer

Vacant - President-Elect

Denis Mee-Lee, MD Immediate Past-President (2019-2020)

Iqbal "Ike" Ahmed, MD - Assembly Rep

Leslie Gise, MD - Assembly Rep

Sara Haack, MD - Early Career Psychiatrist Rep

Megan Araujo, MD - Member in Training Representative

Vacant - Member in Training Deputy Representative

Leslie Gise, MD - Membership Committee Chair

Celia Ona, MD - Ethics Committee Chair

Executive Council - Legislative Chair

Rika Suzuki, MD - Public Affairs Chair

Vacant - Women's Committee Co-Chair

Keiko Chen, MD - Women's Committee Co-Chair

Julienne Ong Aulwes, MD – Chair of the HPMA Task Force on Access to Care

2019-2020 Executive Council

Denis Mee-Lee, MD - President

Vacant - Vice President

Michele Wang, MD - Secretary

Julienne Aulwes, MD - Treasurer

Rika Suzuki, MD - President-Elect

Celia Ona, MD Immediate Past-President (2018-2019)

Iqbal "Ike" Ahmed, MD - Assembly Rep

Leslie Gise, MD - Assembly Rep

Sara Haack, MD - Early Career Psychiatrist Rep

Jing Foongsathaporn, MD - Member in Training Representative

Jing Foongsathaporn, MD - Member in Training Deputy Representative

Leslie Gise, MD - Membership Committee Chair

Celia Ona, MD - Ethics Committee Chair

Executive CouncilLegislative Chair

Rika Suzuki, MD - Public Affairs Chair

Asif Majid, MD - Public Affairs Chair

Michele Wang, MD - Women's Committee Co-Chair

Keiko Chen, MD - Women's Committee Co-Chair

Julienne Ong Aulwes, MD – Chair of the HPMA Task Force on Access to Care

2018-19 Executive Council

Celia Ona, MD - President

Vacant - Vice President

Michele Wang, MD - Secretary

Julienne Aulwes, MD - Treasurer

Denis Mee-Lee, MD - President-Elect

Michael Champion, MD Immediate Past-President (2016-2018)

Iqbal "Ike" Ahmed, MD - Assembly Rep

Leslie Gise, MD - Assembly Rep

Sara Haack, MD - Early Career Psychiatrist Rep

Evan Taniguchi, MD - Member in Training Representative

Chayaninin Foongsathaporn, MD - Member in Training Deputy Representative

Vlad Karpa, MD - Membership Committee Co-Chair

Leslie Gise, MD - Membership Committee Co-Chair

Gregory A. Prier, DO - Ethics Committee Chair

Jeffrey Akaka, MD - Legislative Chair

Rika Suzuki, MD - Public Affairs Chair

Asif Majid, MD - Public Affairs Chair

Michele Wang, MD - Women's Committee Co-Chair

Keiko Chen, MDWomen's Committee Co-Chair

Julienne Ong Aulwes, MD – Chair of the HPMA Task Force on Access to Care

 

 

 


Autism and Adult Psychiatry

October 31, 2012
William M. Bolman, MD

I.  Why do I need to know about Autism?
    1)  Because of the continuing increase in prevalence.  In the last 25 years the prevalence has climbed from 2 per 1,000 to 1 in 54 boys and continues to rise.
    2)  For the past 15 years I have had an autism practice and most of these young people are headed towards adulthood and their parents will be calling you mostly for medication support.
    3)  Many persons with autism also have co-morbid psychiatric conditions that are often responsive to medication.  The most common are anxiety, depression, mood dyscontrol.  A few have psychotic symptoms.  Mostly their medication needs will be stable and continued from late adolescence.

II.  If I see patients with autism, what do I need to know?
    1)  Psychopharmacology.
    2)  How to work with families in general problem-solving.  
    Really, I’m not kidding, most of the technical stuff will have been taken care of during childhood.  At this time the issue is simply maintenance and some general support.  Any continuing problems and you will contact the Autism Society of Hawaii (I’m the president, and if I can’t help I have a very smart Professional Advisory Board.  You can reach me at [email protected].  If you have autistic patients/families and think you need a consult, let me know.  I still see patients for evaluations but not for ongoing psychopharm treatment.

III.  Other than that, I hope most of you know that neuroscience is experiencing an absolutely thrilling period of growth due to technological improvements in neuroimaging and the fields of epigenetics, and systems neurobiology that is beginning to impact psychiatry.  Regarding neuroscience, it is now possible to label a single neuron or group of similar neurons with an optical tracer (a protein that illuminates when exposed to light).  That means one can start tracing brain circuitry.  We have learned that for neurodevelopmental conditions like autism the pathology is not necessarily in the neuron.  Rather it’s in the neuronal support system – astrocytes, oligodendrocyes, and the extracellular matrix including cytokines from the immune system.  In particular, the development and function of the synapse and interneurons is affected.  In epigenetics it is now known that what we were previously told was ‘junk DNA’ actually controls the standard genes in neuronal development and response to the environment.  We know that the reason the autism spectrum conditions affect each individual in different ways and with different severity (the phenotype) is because there is a very large set of genes that interact in multiple ways (genetic pleiotropy – check it out on Wikipedia).  However there are some common molecular pathways such as redox homeostasis (oxidation-reduction cell balance) that may be affected by medications and gene transfer.
    There are a few really interesting insights from all this research.
    1)  Autism, schizophrenia, bipolar disorder, ADHD, learning disabilities and probably intellectual disability (the polite term for MR) share many of the same genes.  
    2)  Some of these conditions, especially autism, improve considerably with early environmental support (“Applied Behavior Analysis”).  It has also been shown in several instances that gene replacement (mostly in mouse models of neurodevelopmental conditions) in adulthood can totally reverse the neuropathology!!!   The implication is that many of these conditions do not represent irreversible brain damage – they represent homeostatic imbalance as cells and neural systems try to adapt to the molecular imbalances.
    3)  Autism (and related conditions) are not merely neurologic conditions.  The immune systems of innate and adaptive immunity are hugely involved due to their joint embryological origin from primal ectoderm.  

SO, stay tuned!   Go into the National Library of Medicine’s website (PubMed), become a member (free), type in “Molecular Neurobiology AND Autism” and enjoy some stuff that did not exist when we were in medical school!

The reason I’m so turned on by all this stuff is because I’m so old that as a young pediatrician I used to treat polio and leukemia, both conditions solved by genetic, immunologic and neuroscientific research, and we are on the same path.

 

Special Reports

2015 Letter from HPMA President Brett Lu, MD, PhD


Board of Trustee Reports

September 2014


 


 
<< first < Prev 1 2 3 4 5 Next > last >>

Page 4 of 5
powered by MemberClicks